These effects of GH are demonstrated in clinical settings, as individuals with decreased GH action are characterized by short stature and obesity,1, 2 and recombinant GH treatment in GH‐deficient adults causes increased lean mass and decreased fat mass.3 The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.